Cambridge, United Kingdom

Alexander I Taylor

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2015-2018

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: **Innovations by Alexander I Taylor: Pioneering Nucleic Acid Polymerases**

Introduction

Alexander I Taylor is a distinguished inventor based in Cambridge, GB, known for his contributions to biotechnology, particularly in the field of enzymes. With two patents to his name, he is making significant strides in the development of nucleic acid polymerases that have applications in genetic research and biotechnology.

Latest Patents

Taylor's latest patents focus on innovative nucleic acid polymerases designed to produce non-DNA nucleotide polymers from DNA templates. One of his notable inventions involves a polymerase that comprises an amino acid sequence with at least 36% identity to SEQ ID NO:1, incorporating specific mutations at the thumb region residues. This includes the significant mutations Y409G and E664K, enhancing the polymerase's functionality. Additionally, another invention addresses the reverse transcription of HNA nucleotide polymers into DNA, showcasing Taylor's versatility and expertise in enzyme engineering.

Career Highlights

Currently, Alexander I Taylor is associated with the Medical Research Council, where his research contributes to groundbreaking advancements in molecular biology. His work not only reflects his expertise but also emphasizes the importance of enzyme innovations in the medical field. Through his patents, Taylor has exhibited a strong commitment to advancing our understanding of nucleic acid processes.

Collaborations

Throughout his career, Taylor has collaborated with notable researchers, including Philipp Holliger and Christopher Cozens. These partnerships enhance the scope and impact of his work, fostering an environment of innovation and collaboration in the scientific community.

Conclusion

In summary, Alexander I Taylor's contributions to enzyme technology through his patents present exciting possibilities for future biomedical applications. His research at the Medical Research Council continues to push the boundaries of genetic engineering, confirming his status as a leading inventor in this vital area of science. As advancements in nucleic acid polymerases evolve, Taylor's work will undoubtedly play a crucial role in the future of biotechnology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…